Blood marker may warn of kidney danger in heart failure patients
NCT ID NCT00561483
First seen Dec 10, 2025 · Last updated May 13, 2026 · Updated 17 times
Summary
This study looked at 64 people hospitalized for acute heart failure to see if a blood marker called cystatin C could predict kidney problems caused by diuretic (water pill) treatment. Researchers measured cystatin C levels daily and compared them to standard kidney tests. The goal was to understand how kidney function changes during heart failure treatment, not to test a new therapy. Results may help design future studies to prevent kidney damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
Conditions
Explore the condition pages connected to this study.